Teratoma Formation Assays - Histology

Relevant Publications

Generation of a human induced pluripotent stem cell line (SHUPLi002-A) from PBMCs of a healthy female donor.

Issue Release: 2024

Loss of Cell-Cell Contact Inhibits Cellular Differentiation of α-Catenin Knock Out P19 Embryonal Carcinoma Cells and Their Colonization into the Developing Mouse Embryos.

Issue Release: 2024

Generation of human induced pluripotent stem cell lines (iPSC) from adipose-derived mesenchymal stromal cells from two patients with systemic sclerosis.

Issue Release: 2024

APE1 promotes embryonic stem cell proliferation and teratoma formation by regulating GDNF/GFRα1 axis.

Issue Release: 2023

Bone regeneration of induced pluripotent stem cells derived from peripheral blood cells in collagen sponge scaffolds.

Issue Release: 2022

Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.

Issue Release: 2022

Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technology.

Issue Release: 2022

Suppression of transient receptor potential melastatin 7 regulates pluripotency, proliferation, and differentiation of mouse embryonic stem cells via mechanistic target of rapamycin-extracellular signal-regulated kinase activation.

Issue Release: 2021

A Quick and Efficient Method for the Generation of Immunomodulatory Mesenchymal Stromal Cell from Human Induced Pluripotent Stem Cell.

Issue Release: 2021

DDB2 regulates DNA replication through PCNA-independent degradation of CDT2.

Issue Release: 2021

Surf4 facilitates reprogramming by activating the cellular response to endoplasmic reticulum stress.

Issue Release: 2021

Using Advanced Cell Culture Techniques to Differentiate Pluripotent Stem Cells and Recreate Tissue Structures Representative of Teratoma Xenografts.

Issue Release: 2021

Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil () Express Immunomodulatory Factors and a Tropism Toward Devil Facial Tumor Cells.

Issue Release: 2020

HIF-1α/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells.

Issue Release: 2020

METTL1-mediated mG methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular development.

Issue Release: 2020

Direct application of induced pluripotent stem cells is feasible and can be safe.

Issue Release: 2019

Generation of Mouse-Induced Pluripotent Stem Cells by Lentiviral Transduction.

Issue Release: 2019

Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges.

Issue Release: 2019

Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods.

Issue Release: 2019

Stem cells: past, present, and future.

Issue Release: 2019

How Can Technology Help Mitigate Delays?

What is Vascular Endothelium?

What Should Participants Bring to Histology Workshops?

What is Thyroxine?

Why is Low Background Noise Important?

What Stains and Techniques are Used to Study Non-Caseating Granulomas?

What is the Role of Beta Barrels in Disease?

How to Differentiate Between Different Tissue Types?

What Research Advances Have Been Made in Understanding GALT?

What Types of Pollutants are Studied in Histology?

Teratoma Formation Assays - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics